Names | |
---|---|
Preferred IUPAC name
4-[(Dimethylcarbamoyl)oxy]-N,N,N-trimethyl-2-(propan-2-yl)anilinium iodide | |
Other names
SB-8
| |
Identifiers | |
3D model (
JSmol)
|
|
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C15H25IN2O2 | |
Molar mass | 392.281 g·mol−1 |
Hazards | |
Lethal dose or concentration (LD, LC): | |
LD50 (
median dose)
|
75 μg/kg (subcutaneous, mice)
[1] 168 μg/kg (intraperitoneal, mice) [1] 75 μg/kg (mice, subcutaneous) [2] |
LDLo (
lowest published)
|
100 μg/kg (guinea pigs, subcutaneous) [1] |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
TL-599, also known as SB-8, is an extremely potent carbamate acetylcholinesterase inhibitor. [1] [2]